Compare AMRX & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | LGN |
|---|---|---|
| Founded | 2002 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.3B |
| IPO Year | 2018 | 2025 |
| Metric | AMRX | LGN |
|---|---|---|
| Price | $17.94 | $60.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 17 |
| Target Price | $15.60 | ★ $59.50 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 05-01-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | N/A | ★ $2,550,491,000.00 |
| Revenue This Year | $4.48 | $53.66 |
| Revenue Next Year | $7.13 | $11.99 |
| P/E Ratio | $48.95 | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $9.20 | $28.31 |
| 52 Week High | $19.26 | $107.24 |
| Indicator | AMRX | LGN |
|---|---|---|
| Relative Strength Index (RSI) | 51.26 | 43.57 |
| Support Level | $16.61 | $42.97 |
| Resistance Level | $18.13 | $70.80 |
| Average True Range (ATR) | 0.67 | 3.75 |
| MACD | -0.09 | 0.35 |
| Stochastic Oscillator | 48.32 | 14.50 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Legence Corp is a provider of engineering, installation, and maintenance services for critical systems in buildings. It focuses on sectors that have technically demanding buildings, including technology, life sciences, healthcare, and education. Legence specializes in designing, fabricating, and installing complex heating, ventilation, and air conditioning (HVAC), process piping, and other mechanical, electrical, and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting, and building controls in existing facilities to enhance building performance, reliability, and efficiency. The services are mainly provided on a fixed price basis. The company has two reportable segments: Installation and Maintenance, which generates the maximum revenue, and Engineering and Consulting.